BCOR is a gene that encodes for an epigenetic regulator involved in the specification of cell differentiation and body structure development and takes part in the noncanonical polycomb repressive complex 1. This review provides a comprehensive summary of BCOR's involvement in oncology, illustrating that various BCOR aberrations, such as the internal tandem duplications of the PCGF Ub-like fold discriminator domain and different gene fusions (mainly BCOR-CCNB3, BCOR-MAML3 and ZC3H7B-BCOR), represent driver elements of various sarcomas such as clear cell sarcoma of the kidney, primitive mesenchymal myxoid tumor of infancy, small round blue cell sarcoma, endometrial stromal sarcoma and histologically heterogeneous CNS neoplasms group with similar genomic methylation patterns known as CNS-HGNET-BCOR. Furthermore, other BCOR alterations (often loss of function mutations) recur in a large variety of mesenchymal, epithelial, neural and hematological tumors, suggesting a central role in cancer evolution.

Astolfi, A., Fiore, M., Melchionda, F., Indio, V., Bertuccio, S.N., Pession, A. (2019). BCOR involvement in cancer. EPIGENOMICS, 11(7), 835-855 [10.2217/epi-2018-0195].

BCOR involvement in cancer

Astolfi, Annalisa;FIORE, MICHELE;Indio, Valentina;Bertuccio, Salvatore N;Pession, Andrea
2019

Abstract

BCOR is a gene that encodes for an epigenetic regulator involved in the specification of cell differentiation and body structure development and takes part in the noncanonical polycomb repressive complex 1. This review provides a comprehensive summary of BCOR's involvement in oncology, illustrating that various BCOR aberrations, such as the internal tandem duplications of the PCGF Ub-like fold discriminator domain and different gene fusions (mainly BCOR-CCNB3, BCOR-MAML3 and ZC3H7B-BCOR), represent driver elements of various sarcomas such as clear cell sarcoma of the kidney, primitive mesenchymal myxoid tumor of infancy, small round blue cell sarcoma, endometrial stromal sarcoma and histologically heterogeneous CNS neoplasms group with similar genomic methylation patterns known as CNS-HGNET-BCOR. Furthermore, other BCOR alterations (often loss of function mutations) recur in a large variety of mesenchymal, epithelial, neural and hematological tumors, suggesting a central role in cancer evolution.
2019
Astolfi, A., Fiore, M., Melchionda, F., Indio, V., Bertuccio, S.N., Pession, A. (2019). BCOR involvement in cancer. EPIGENOMICS, 11(7), 835-855 [10.2217/epi-2018-0195].
Astolfi, Annalisa; Fiore, Michele; Melchionda, Fraia; Indio, Valentina; Bertuccio, Salvatore N; Pession, Andrea
File in questo prodotto:
File Dimensione Formato  
epi-2018-0195.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione 863.56 kB
Formato Adobe PDF
863.56 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/693181
Citazioni
  • ???jsp.display-item.citation.pmc??? 40
  • Scopus 124
  • ???jsp.display-item.citation.isi??? 108
social impact